{"name":"Amobarbital","slug":"amobarbital","kind":"substance","abbreviations":[],"systematic":null,"aliases":["Amylobarbitone","Isomytal","Amylobarbital","Barbamil","Barbamyl","Amytal","Amobarbitone","Amylbarbitone","Barbamyl acid","Pentymalum"],"brands":[],"scraped":true,"has_structure":true,"cid":2164,"classes":[],"families":[{"name":"barbiturate","href":"/substituted/barbiturate"}],"physical":[{"label":"Molecular mass","value":"226.27 g/mol","copyable":false},{"label":"Appearance","value":"Crystals","copyable":false},{"label":"Odor","value":"Odorless","copyable":false},{"label":"Taste","value":"Slightly bitter","copyable":false},{"label":"Melting point","value":"313 to 316 °F (NTP, 1992)","copyable":false},{"label":"Decomposition","value":"When heated to decomposition, it emits toxic fumes of /nitric oxides/.","copyable":false},{"label":"Solubility","value":"less than 1 mg/mL at 65.3 °F (NTP, 1992)","copyable":false},{"label":"Predicted LogP","value":"2.1","copyable":false}],"identifiers":[{"label":"Molecular formula","value":"C<sub>11</sub>H<sub>18</sub>N<sub>2</sub>O<sub>3</sub>","copyable":true},{"label":"IUPAC name","value":"5-ethyl-5-(3-methylbutyl)-1,3-diazinane-2,4,6-trione","copyable":true},{"label":"SMILES","value":"CCC1(C(=O)NC(=O)NC1=O)CCC(C)C","copyable":true},{"label":"InChI","value":"InChI=1S/C11H18N2O3/c1-4-11(6-5-7(2)3)8(14)12-10(16)13-9(11)15/h7H,4-6H2,1-3H3,(H2,12,13,14,15,16)","copyable":true},{"label":"InChIKey","value":"VIROVYVQCGLCII-UHFFFAOYSA-N","copyable":true},{"label":"CAS number","value":"57-43-2","copyable":true},{"label":"UNII","value":"GWH6IJ239E","copyable":true},{"label":"PubChem CID","value":"2164","copyable":true}],"pharmacokinetics":[{"label":"Elimination half-life","value":"8–42 hours","copyable":false},{"label":"Metabolism","value":"Hepatic","copyable":false},{"label":"Excretion","value":"Renal","copyable":false},{"label":"Routes of administration","value":"By mouth, intramuscular, intravenous, rectal","copyable":false}],"toxicity":[{"kind":"LD50","organisms":[["Mouse",[{"kind":"LD50","organism":"Mouse","route":"oral","dose":"345 mg/kg"}]],["Rat",[{"kind":"LD50","organism":"Rat","route":"oral","dose":"250 mg/kg"},{"kind":"LD50","organism":"Rat","route":"ip","dose":"115 mg/kg /Amobarbital"},{"kind":"LD50","organism":"Rat","route":"sc","dose":"190 mg/kg"}]]]}],"dosing":null,"salts":[{"title":"Sodium amobarbital","name":"sodium","slug":"sodium_amobarbital","drawn":true}],"esters":[],"chirality":"achiral","stereo_type":null,"optical_activity":null,"stereoisomers":[],"lipinski":{"passes":true,"violations":0},"reagents":[],"atc":[{"code":"N","description":"Nervous system"},{"code":"N05","description":"Psycholeptics"},{"code":"N05C","description":"Hypnotics and sedatives"},{"code":"N05CA","description":"Barbiturates, plain"},{"code":"N05CA02","description":"Amobarbital"}],"mesh":[{"name":"Hypnotics and Sedatives","id":"M0010885"},{"name":"GABA Modulators","id":"M0028093"}],"actives":[],"prodrugs":[],"codrug":false,"interactions":[{"target":"CYP3A","mechanisms":["induction"],"partners":41,"contraindicated":1},{"target":"GABRA1","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRA2","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRA3","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRA4","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRA5","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRA6","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRB1","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRB2","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRB3","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRD","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRE","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRG1","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRG2","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRG3","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRP","mechanisms":["shared target"],"partners":33,"contraindicated":0},{"target":"GABRQ","mechanisms":["shared target"],"partners":33,"contraindicated":0}],"mechanism":"Amobarbital (like all barbiturates) works by binding to the GABAA receptor at either the alpha or the beta sub unit.  These are binding sites that are distinct from GABA itself and also distinct from the benzodiazepine binding site. Like benzodiazepines, barbiturates potentiate the effect of GABA at this receptor.  This GABAA receptor binding decreases input resistance, depresses burst and tonic firing, especially in ventrobasal and intralaminar neurons, while at the same time increasing burst duration and mean conductance at individual chloride channels; this increases both the amplitude and decay time of inhibitory postsynaptic currents.  In addition to this GABA-ergic effect, barbiturates also block the AMPA receptor, a subtype of glutamate receptor. Glutamate is the principal excitatory neurotransmitter in the mammalian CNS.  Amobarbital also appears to bind neuronal nicotinic acetylcholine receptors.","side_effects":{"drug_id":2163,"drug_name":"amobarbital","url":"https://sideeffects.embl.de/drugs/2163/pt","atc_codes":["N05CA02"],"side_effects":[{"name":"Anaemia megaloblastic","cui":"C0002888"},{"name":"Angioedema","cui":"C0002994"},{"name":"Anxiety","cui":"C0003467"},{"name":"Apnoea","cui":"C0003578"},{"name":"Ataxia","cui":"C0004134"},{"name":"Atelectasis","cui":"C0004144"},{"name":"Pneumothorax","cui":"C0032326"},{"name":"Confusional state","cui":"C0009676"},{"name":"Feeling abnormal","cui":"C1443060"},{"name":"Constipation","cui":"C0009806"},{"name":"Dermatitis exfoliative","cui":"C0011606"},{"name":"Dizziness","cui":"C0012833"},{"name":"Syncope","cui":"C0039070"},{"name":"Dermatitis","cui":"C0011603"},{"name":"Rash","cui":"C0015230"},{"name":"Body temperature increased","cui":"C0015967"},{"name":"Hallucination","cui":"C0018524"},{"name":"Headache","cui":"C0018681"},{"name":"Hypersensitivity","cui":"C0020517"},{"name":"Hypotension","cui":"C0020649"},{"name":"Nausea","cui":"C0027497"},{"name":"Nervousness","cui":"C0027769"},{"name":"Tension","cui":"C0233494"},{"name":"Nightmare","cui":"C0028084"},{"name":"Shock","cui":"C0036974"},{"name":"Loss of consciousness","cui":"C0041657"},{"name":"Vomiting","cui":"C0042963"},{"name":"Agitation","cui":"C0085631"},{"name":"Hyperkinesia","cui":"C0424295"},{"name":"Depressed level of consciousness","cui":"C0549249"},{"name":"Injection site reaction","cui":"C0151735"},{"name":"Hepatocellular injury","cui":"C0151763"},{"name":"Liver injury","cui":"C0160390"},{"name":"Thinking abnormal","cui":"C0233632"},{"name":"Mental disability","cui":"C1306341"},{"name":"Bradycardia","cui":"C0428977"},{"name":"Somnolence","cui":"C2830004"},{"name":"Hypoxia","cui":"C0242184"},{"name":"Respiratory failure","cui":"C1145670"},{"name":"Hypoventilation","cui":"C3203358"}],"indications":[{"name":"Insomnia","cui":"C0917801"}]},"effects":null,"usernotes":[],"erowid":[],"reddit":[],"legal":[{"jurisdiction":"Brazil","status":"B1","act":null,"refs":[3]},{"jurisdiction":"Canada","status":"Schedule IV","act":null,"refs":[]},{"jurisdiction":"Germany","status":"Anlage III","act":"Betäubungsmittelgesetz (BtMG)","refs":[]},{"jurisdiction":"United States","status":"Schedule II / Schedule III","act":"Controlled Substances Act","refs":[]},{"jurisdiction":"United Kingdom","status":"Class B","act":"Misuse of Drugs Act 1971","refs":[]},{"jurisdiction":"United Nations","status":"Schedule III psychotropic","act":"Convention on Psychotropic Substances 1971","refs":[]},{"jurisdiction":"Other","status":"SE: Förteckning IV","act":null,"refs":[]}],"members":[],"part_of":[],"links":[{"source":"Wikipedia","url":"https://en.wikipedia.org/wiki/Amobarbital"},{"source":"PubChem","url":"https://pubchem.ncbi.nlm.nih.gov/compound/2164"},{"source":"Wikidata","url":"https://www.wikidata.org/wiki/Q415850"},{"source":"DrugBank","url":"https://go.drugbank.com/drugs/DB01351"},{"source":"ChEMBL","url":"https://www.ebi.ac.uk/chembl/explore/compound/CHEMBL267894"},{"source":"ChEBI","url":"https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI%3A2673"},{"source":"Common Chemistry","url":"https://commonchemistry.cas.org/detail?cas_rn=57-43-2"},{"source":"HMDB","url":"https://hmdb.ca/metabolites/HMDB0015440"},{"source":"KEGG","url":"https://www.kegg.jp/entry/D00555"},{"source":"EPA DSSTox","url":"https://comptox.epa.gov/dashboard/chemical/details/DTXSID9020081"},{"source":"Effect Index","url":"https://www.effectindex.com/search?q=Amobarbital"},{"source":"UNII","url":"https://gsrs.ncats.nih.gov/ginas/app/ui/substances/GWH6IJ239E"},{"source":"SIDER","url":"https://sideeffects.embl.de/drugs/2163/pt"}],"references":["National Center for Biotechnology Information. PubChem Compound Summary for CID 2164, Amobarbital. Accessed November 21, 2026. <a href=https://pubchem.ncbi.nlm.nih.gov/compound/2164>https://pubchem.ncbi.nlm.nih.gov/compound/2164</a>","U.S. Food and Drug Administration; National Center for Advancing Translational Sciences. Amobarbital. UNII: GWH6IJ239E. Global Substance Registration System. Accessed November 21, 2026. <a href=https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GWH6IJ239E>https://gsrs.ncats.nih.gov/ginas/app/beta/substances/GWH6IJ239E</a>","RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial. Diário Oficial da União. 2023-03-31. <a href='https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992'>https://www.in.gov.br/en/web/dou/-/resolucao-rdc-n-784-de-31-de-marco-de-2023-474904992</a>"],"sources":[{"source":"dosing","status":"missing","fetched_at":"2026-11-20 18:01:25","note":"no dosing statistics"},{"source":"drugspro","status":"missing","fetched_at":"2026-11-20 18:01:21","note":"no DrugsPRO reagent data"},{"source":"erowid","status":"missing","fetched_at":"2026-11-20 18:01:21","note":"no Erowid substance of that name"},{"source":"gsrs","status":"ok","fetched_at":"2026-11-20 18:01:22","note":null},{"source":"hmdb","status":"missing","fetched_at":"2026-11-20 18:01:21","note":"hmdb.ca refused automated access to HMDB0015440"},{"source":"kegg","status":"ok","fetched_at":"2026-11-20 18:01:23","note":null},{"source":"pubchem","status":"ok","fetched_at":"2026-11-20 18:01:21","note":null},{"source":"reddit","status":"missing","fetched_at":"2026-11-20 18:01:21","note":"no r/tripreports posts mention it"},{"source":"sider","status":"ok","fetched_at":"2026-11-20 18:01:21","note":null},{"source":"structure","status":"ok","fetched_at":"2026-11-20 18:01:21","note":null},{"source":"wikipedia","status":"ok","fetched_at":"2026-11-20 18:01:21","note":null}],"description":"Amobarbital is a  substance."}